MediWound Ltd. - Common Shares (MDWD)

Historical Holders from Q1 2014 to Q1 2023

Type / Class
Equity / Common Shares
Symbol
MDWD on Nasdaq
Shares outstanding
13,033,129
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MediWound Ltd. - Common Shares (MDWD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rosalind Advisors, Inc. 7% +36% 912,319 +60% Rosalind Advisors, Inc. 30 Sep 2025
HOLD Alapkezelo Zrt. 6.5% 703,429 HOLD Alapkezelo Zrt. 22 Sep 2025

Institutional Holders of MediWound Ltd. - Common Shares (MDWD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2023 Q1 0 $0 -$479,633 0
2022 Q4 36,502 $479,633 -$13,799,639 1,313.99% 1
2022 Q3 7,937,569 $11,051,900 +$7,717,704 139% 25
2022 Q2 3,010,957 $5,536,400 +$414,234 183.94% 18
2022 Q1 2,783,128 $5,537,527 -$1,734,087 199.13% 24
2021 Q4 3,651,187 $8,621,369 +$265,274 235.95% 26
2021 Q3 3,537,329 $11,810,598 -$1,010,482 333.91% 26
2021 Q2 3,554,167 $13,611,000 -$5,839,432 382.96% 22
2021 Q1 4,873,780 $26,165,480 +$845,846 537% 26
2020 Q4 4,815,044 $17,807,000 +$813,085 369.97% 26
2020 Q3 4,602,714 $17,302,000 +$175,324 376.06% 23
2020 Q2 4,541,001 $13,488,000 -$4,972,482 296.83% 22
2020 Q1 5,995,653 $9,413,000 -$1,027,790 156.97% 19
2019 Q4 6,818,030 $21,134,000 -$831,535 309.83% 22
2019 Q3 7,080,144 $22,560,000 -$2,305,131 319.79% 18
2019 Q2 7,809,443 $26,399,000 -$2,050,719 338.07% 22
2019 Q1 8,362,104 $41,810,000 +$1,413,132 500.03% 23
2018 Q4 8,111,968 $32,932,000 -$2,741,341 405.87% 21
2018 Q3 8,629,094 $53,199,185 -$1,808,564 615.12% 24
2018 Q2 8,807,017 $60,564,207 +$272,308 689.96% 18
2018 Q1 8,857,162 $46,061,156 -$153,494 520% 19
2017 Q4 8,889,781 $39,561,000 +$1,410,540 445% 22
2017 Q3 7,965,343 $42,498,000 +$15,117,304 534.45% 19
2017 Q2 5,150,789 $35,025,000 -$4,714,729 680.13% 18
2017 Q1 5,854,412 $38,639,000 -$638,532 659.99% 17
2016 Q4 6,004,784 $27,430,785 -$231,986 457.9% 20
2016 Q3 5,782,231 $44,519,090 -$21,022 769.91% 20
2016 Q2 5,785,106 $45,516,413 +$22,619,157 788.62% 18
2016 Q1 2,910,668 $23,487,719 +$44,636 806.99% 15
2015 Q4 2,903,686 $24,799,518 +$224,492 854.03% 18
2015 Q3 2,879,689 $21,970,890 +$2,483,333 762.97% 17
2015 Q2 2,555,675 $18,069,199 -$1,434,479 707% 17
2015 Q1 2,756,482 $20,149,213 +$803,659 724.07% 15
2014 Q4 2,450,926 $16,322,117 -$4,950,441 665.89% 15
2014 Q3 3,142,395 $19,716,000 -$4,131,129 629.42% 21
2014 Q2 3,581,061 $40,741,000 +$34,275,128 1,137.93% 21
2014 Q1 568,214 $8,188,000 +$8,188,021 1,441.01% 1